These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9839087)

  • 1. Clinical pharmacokinetics of acamprosate.
    Saivin S; Hulot T; Chabac S; Potgieter A; Durbin P; Houin G
    Clin Pharmacokinet; 1998 Nov; 35(5):331-45. PubMed ID: 9839087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats.
    Zornoza T; Cano-Cebrián MJ; Hipólito L; Granero L; Polache A
    Biopharm Drug Dispos; 2006 Oct; 27(7):305-11. PubMed ID: 16799924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic study of acamprosate absorption in rat small intestine.
    Más-Serrano P; Granero L; Martín-Algarra RV; Guerri C; Polache A
    Alcohol Alcohol; 2000; 35(4):324-30. PubMed ID: 10905995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex.
    al Qatari M; Bouchenafa O; Littleton J
    Alcohol Clin Exp Res; 1998 Jun; 22(4):810-4. PubMed ID: 9660305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acamprosate for the adjunctive treatment of alcohol dependence.
    Overman GP; Teter CJ; Guthrie SK
    Ann Pharmacother; 2003; 37(7-8):1090-9. PubMed ID: 12841823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of acamprosate: an overview.
    Zornoza T; Cano MJ; Polache A; Granero L
    CNS Drug Rev; 2003; 9(4):359-74. PubMed ID: 14647529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
    Kim SG; Han BD; Park JM; Kim MJ; Stromberg MF
    Psychiatry Clin Neurosci; 2004 Feb; 58(1):30-6. PubMed ID: 14678454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of acamprosate calcium in healthy Chinese subjects after oral administration of three dosage levels.
    Xu F; Qing Y; Shang B; Liang M; Zou Y; Xu G
    Arzneimittelforschung; 2009; 59(12):631-4. PubMed ID: 20108648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of acamprosate in the rat: influence of probenecid.
    Zornoza T; Guerri C; Polache A; Granero L
    Biopharm Drug Dispos; 2002 Oct; 23(7):283-91. PubMed ID: 12355579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets.
    Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Lee DS; Park ES
    Arch Pharm Res; 2008 Jun; 31(6):798-804. PubMed ID: 18563364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers.
    Hammarberg A; Beck O; Eksborg S; Jayaram-Lindström N; Lindefeldt A; Andersson M; Brundin L; Reid MS; Franck J
    Ther Drug Monit; 2010 Aug; 32(4):489-96. PubMed ID: 20592646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.
    Mason BJ; Goodman AM; Dixon RM; Hameed MH; Hulot T; Wesnes K; Hunter JA; Boyeson MG
    Neuropsychopharmacology; 2002 Oct; 27(4):596-606. PubMed ID: 12377396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the combined administration of ethanol and acamprosate on rabbit EEG.
    Pietrzak B; Czarnecka E
    Pharmacol Rep; 2005; 57(1):61-9. PubMed ID: 15849378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour.
    Gewiss M; Heidbreder C; Opsomer L; Durbin P; De Witte P
    Alcohol Alcohol; 1991; 26(2):129-37. PubMed ID: 1652250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate suppresses ethanol-induced place preference in mice with ethanol physical dependence.
    Kurokawa K; Mizuno K; Shibasaki M; Higashioka M; Oka M; Hirouchi M; Ohkuma S
    J Pharmacol Sci; 2013; 122(4):289-98. PubMed ID: 23903008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.
    Heyser CJ; Schulteis G; Durbin P; Koob GF
    Neuropsychopharmacology; 1998 Feb; 18(2):125-33. PubMed ID: 9430136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat.
    Spanagel R; Hölter SM; Allingham K; Landgraf R; Zieglgänsberger W
    Eur J Pharmacol; 1996 Jun; 305(1-3):39-44. PubMed ID: 8813529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration.
    Burattini C; McGeehan AJ; Griffin WC; Gass JT; Kinder JR; Janak PH; Olive MF
    Addict Biol; 2008 Mar; 13(1):70-9. PubMed ID: 18269381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.
    Lidö HH; Marston H; Ericson M; Söderpalm B
    Addict Biol; 2012 Sep; 17(5):897-907. PubMed ID: 21955180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.